Immune recovery folliculitis: Case reports in HIV naïve and experienced patients.

ART, Antiretroviral Therapy BIC/F/TAF, Bictegravir/Emtricitabina/Tenofovir alafenamide fumarate CDC, Centers for Disease Control Case report DRV/c, Darunavir/cobicistat E/C/F/TAF, Elvitegravir/cobicistat/Emtricitabina/Tenofovir alafenamide fumarate HIV infection HIV, Human Immunodeficiency Virus IRF, Immune Recovery Folliculitis IRIS, Immune Reconstitution Inflammatory Syndrome Immune reconstitution inflammatory syndrome Immune recovery folliculitis LPV/r, Lopinavir/ritonavir RAL, Raltegravir TAF/FTC, Tenofovir alafenamide fumarate/Emtricitabina TDF/FTC, Tenofovir disoproxil fumarate/Emtricitabine Therapy simplification VL, Viral Load

Journal

IDCases
ISSN: 2214-2509
Titre abrégé: IDCases
Pays: Netherlands
ID NLM: 101634540

Informations de publication

Date de publication:
2021
Historique:
received: 14 09 2021
revised: 26 10 2021
accepted: 26 10 2021
entrez: 15 11 2021
pubmed: 16 11 2021
medline: 16 11 2021
Statut: epublish

Résumé

Immune recovery folliculitis (IRF) is defined as the development of an inflammatory disorder of the facial pilo-sebaceous unit due to the immune reconstitution inflammatory syndrome (IRIS). Skin lesions can be related to an immune response against skin saprophyte bacteria (e.g.

Identifiants

pubmed: 34777994
doi: 10.1016/j.idcr.2021.e01324
pii: S2214-2509(21)00280-8
pmc: PMC8577432
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e01324

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

MC, AS, FDN, DC have not any potential competing interests. RG received speakers’s honoraria from ViiV Healthcare, MSD and Gilead; grants for advisory board from ViiV Healthcare and Janssen. AA has served as a paid consultant to Gilead, Janssen, Merck, and ViiV Healthcare and received research funding from Gilead, Janssen, and ViiV Healthcare.

Références

Clin Dermatol. 2004 Sep-Oct;22(5):375-9
pubmed: 15556721
Br J Dermatol. 1999 Jul;141(1):3-11
pubmed: 10417509
J Eur Acad Dermatol Venereol. 2002 Nov;16(6):638
pubmed: 12482054
AIDS. 2000 Mar 31;14(5):617-8
pubmed: 10780726
Neurology. 2013 Sep 10;81(11):964-70
pubmed: 23935178
Am J Med. 2001 Jun 1;110(8):605-9
pubmed: 11382367
PLoS One. 2019 Apr 25;14(4):e0215991
pubmed: 31022273
Semin Diagn Pathol. 2017 Jul;34(4):340-351
pubmed: 28552210

Auteurs

Marta Camici (M)

HIV/AIDS Clinical Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Alessandra Scarabello (A)

Dermatological Clinical Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Franca Del Nonno (F)

Histology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Daniele Colombo (D)

Histology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Roberta Gagliardini (R)

HIV/AIDS Clinical Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Andrea Antinori (A)

HIV/AIDS Clinical Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Classifications MeSH